MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Obstetrics, Gynecology (OB/GYN) _ Women's Health, Maternal, Pregnancy, Menopause
Daré Bioscience, Inc.(NASDAQ:DARE)
Organization & Developments: Dare' Bioscience
Parents
Daré Bioscience, Inc.(NASDAQ:DARE)
Children
2020: Dare Bioscience: Preparing For The Upcoming Phase 3 Results_seekingalpha
2020: DARE had kicked off its pivotal trial for the candidate in patients with bacterial vaginosis (BV)
2020: DARE-BV1 is a bio-adhesive formulation of clindamycin phosphate 2% that, in a previous proof-of-concept study, generated an 86% clinical cure rate of BV
2021: Diving Into Daré Bioscience
2022: Daré Bioscience, Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
Jumps
*Key People: Dare' Bioscience
Finance & Acquisitions: Dare